Evidence map›Paper›PMID 25728371›Full record

ArticleJournal of chromatography. B, Analytical technologies in the biomedical and life sciences2015

Development of sample clean up methods for the analysis of Mycobacterium tuberculosis methyl mycocerosate biomarkers in sputum extracts by gas chromatography-mass spectrometry.

Simona C Nicoara, Nicholas W Turner, David E Minnikin, Oona Y-C Lee, Denise M O'Sullivan, Ruth McNerney, Reggie Mutetwa, Liz E Corbett, Geraint H Morgan

Open access · hybridAbstract read
In one paragraph

Article in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Simona C NicoaraCentre for Earth, Planetary, Space and Astronomical Research CEPSAR, The Open University, Milton Keynes, UK. Electronic address: simona.nicoara@open.ac.uk.
Nicholas W TurnerLife, Health and Chemical Sciences, The Open University, Milton Keynes, UK.
David E MinnikinInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, UK.
Oona Y-C LeeInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, UK.
Denise M O'SullivanLondon School of Hygiene & Tropical Medicine, London, UK.
Ruth McNerneyLondon School of Hygiene & Tropical Medicine, London, UK.
Reggie MutetwaBiomedical Research and Training Institute, Harare, Zimbabwe.
Liz E CorbettBiomedical Research and Training Institute, Harare, Zimbabwe.
Geraint H MorganCentre for Earth, Planetary, Space and Astronomical Research CEPSAR, The Open University, Milton Keynes, UK.
The Open University · GBLondon School of Hygiene & Tropical Medicine · GBUniversity of Birmingham · GBUniversity of Zimbabwe · ZW

Funding

Wellcome Trust 083597Wellcome Trust 091769
6 · The paper itself

Abstract

A proof of principle gas chromatography-mass spectrometry method is presented, in combination with clean up assays, aiming to improve the analysis of methyl mycocerosate tuberculosis biomarkers from sputum. Methyl mycocerosates are generated from the transesterification of phthiocerol dimycocerosates (PDIMs), extracted in petroleum ether from sputum of tuberculosis suspect patients. When a high matrix background is present in the sputum extracts, the identification of the chromatographic peaks corresponding to the methyl derivatives of PDIMs analytes may be hindered by the closely eluting methyl ether of cholesterol, usually an abundant matrix constituent frequently present in sputum samples. The purification procedures involving solid phase extraction (SPE) based methods with both commercial Isolute-Florisil cartridges, and purpose designed molecularly imprinted polymeric materials (MIPs), resulted in cleaner chromatograms, while the mycocerosates are still present. The clean-up performed on solutions of PDIMs and cholesterol standards in petroleum ether show that, depending on the solvent mix and on the type of SPE used, the recovery of PDIMs is between 64 and 70%, whilst most of the cholesterol is removed from the system. When applied to petroleum ether extracts from representative sputum samples, the clean-up procedures resulted in recoveries of 36-68% for PDIMs, allowing some superior detection of the target analytes.

Indexed as

Antigens, BacterialBiomarkersGas Chromatography-Mass SpectrometryHumansLipidsMolecular ImprintingMycobacterium tuberculosisSolid Phase ExtractionSputumAntigens, BacterialBiomarkersLipidsphthiocerol dimycocerosateCholesterolGC–MSMolecularly imprinted polymersMycobacterium tuberculosisSolid phase extractionThermochemolysis

Identifiers

PMID25728371
PMCPMC4381843
OpenAlexW2042129650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.